|
[1]LU LG.Advances in early screening and diagnosis of hepatocellular carcinoma[J].J Clin Hepatol, 2017, 33 (7) :1257-1261. (in Chinese) .陆伦根.原发性肝癌的早期筛查及诊断[J].临床肝胆病杂志, 2017, 33 (7) :1257-1261.
|
|
[2]KRISHNAN S, MADSEN E, PORTERFILEL D, et al.Advancing cervical cancer prevention in India:implementation science priorities[J].Oncologist, 2013, 18 (Suppl) :13-25.
|
|
[3]ZHANG CY, FU Y, LI XD, et al.Advances in imaging diagnosis of liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1266-1269. (in Chinese) .张春雨, 付宇, 李晓东, 等.肝癌的影像学诊断进展[J].临床肝胆病杂志, 2017, 33 (7) :1266-1269.
|
|
[4]KIERANS AS, KANG SK, ROSENKRANTZ AB, et al.The diagnostic performance of dynamic contrast enhanced mr imaging for detection of small hepatocellular carcinoma measuring up to 2 cm:a meta-analysis[J].Radiology, 2016, 278 (1) :82-94.
|
|
[5]BLONDIN D, ERHARDT A, CRYNEN K, et al.Diagnosis of focal liver lesions in cirrhotic patients:comparison of contrast-enhanced ultrasound using sulphur hexafluoride (SF6) microbubbles and MRI using Gd-EOB-DTPA[J].Z Gastroenterol, 2011, 49 (1) :23-29.
|
|
[6]SAADATPOUR Z, REZAEI A, EBRAHIMNEJAD H, et al.Imaging techniques:new avenues in cancer gene and cell therapy[J].Cancer Gene Ther, 2017, 24 (1) :1-5.
|
|
[7]OKAMURA S, SUMIE S, TONAN T, et al.Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma[J].Dig Liver Dis, 2016, 48 (8) :945-952.
|
|
[8]HERNANDEZ R, SUN H, ENGLAND CG, et al.CD146-targeted immuno PET and NIRF imaging of hepatocellular carcinoma with a dual-labeled monoclonal antibody[J].Theranostics, 2016, 6 (11) :1918-1933.
|
|
[9]WACHSMANN J, PENG F.Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma[J].World J Gastroenterol, 2016, 22 (1) :221-231.
|
|
[10]CARAVAN P, DAS B, DUMAS S, et al.Collagen-targeted MRI contrast agent for molecular imaging of fibrosis[J].Angew Chem Int Ed Engl, 2007, 46 (43) :8171-8173.
|
|
[11]LI YW, CHEN ZG, ZHAO ZS, et al.Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma[J].World J Gastroenterol, 2015, 21 (14) :4275-4283.
|
|
[12]LIU J, ZHOU S, REN J, et al.A lysosome-locating and acidic p H-activatable fluorescent probe for visualizing endogenous H2O2in lysosomes[J].Analyst, 2017, 142 (23) :4522-4528.
|
|
[13]LIU C, GAO Z, ZENG J, et al.Magnetic/upconversion fluorescent Na Gd F4:Yb, Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo[J].ACS Nano, 2013, 7 (8) :7227-7240.
|
|
[14]WANG LW, LIU YY, BAI Y, et al.Study of early warning of liver cancer by AFP-L3 determined in AFP low concentrations[J].J Binzhou Med Univ, 2012, 35 (5) :362-364. (in Chinese) 王连文, 刘永云, 白玉, 等.甲胎蛋白异质体L3在甲胎蛋白低浓度时预警肝癌的研究[J].滨州医学院学报, 2012, 35 (5) :362-364.
|
|
[15]SONG JH.Specific MR imaging of hepatocellular carcinoma using AFP-targeted USPIO molecular probe[D].Jinan:Shandong Univ, 2012. (in Chinese) 宋吉慧.AFP靶向USPIO分子探针在肝癌特异性MR成像中的价值[D].济南:山东大学, 2012.
|
|
[16]LI Y, CHEN Z, LI F, et al.Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide anti GPC3 probe for hepatocellular carcinoma[J].Int J Nanomedicine, 2012, 7:4593-4611.
|
|
[17]KIM KI, CHUNG HK, PARK JH, et al.Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma[J].World J Gastroenterol, 2016, 22 (27) :6127-6134.
|
|
[18]KIM S, YOUN H, SONG MG, et al.Complementary treatment of si TERT for improving the antitumor effect of TERT-specific I-131therapy[J].Cancer Gene Ther, 2012, 19 (4) :263-270.
|
|
[19]BHANG HE, GABEIELSON KL, LATERRA J, et al.Tumorspecific imaging through progression elevated gene-3 promoterdriven gene expression[J].Nat Med, 2011, 17 (1) :123-129.
|
|
[20]PARK JH, KIM KI, LEE KC, et al.Assessment ofα-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging[J].Cancer Biother Radiopharm, 2015, 30 (1) :8-15.
|
|
[21]KASEB AO, HASSAN M, LACIN S, et al.Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma[J].Oncotarget, 2016, 7 (43) :69916-69926.
|
|
[22]JEON Y, JANG ES, CHIO YS, et al.Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alphafetoprotein level for hepatocellular carcinoma diagnosis[J].Clin Mol Hepatol, 2016, 22 (3) :359-365.
|
|
[23]LIU X, WANG SK, ZHANG K, et al.Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers[J].Carcinogenesis, 2015, 36 (2) :232-242.
|
|
[24]SHAM JG, KIEVIT FM, GRIERSON JR, et al.Glypican-3-targeting F (ab') 2 for 89Zr PET of hepatocellular carcinoma[J].J Nucl Med, 2014, 55 (12) :2032-2037.
|
|
[25]LEE YL, AHN BC, LEE Y, et al.Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand[J].J Pept Sci, 2011, 17 (11) :763-769.
|
|
[26]LI WY.MR Molecular Imaging Shidies of Glypican-3-targeting pretargeting technology for hepatocellular carcinoma[D].Guangzhou:Southern Med Univ, 2015. (in Chinese) 李维粤.靶向磷脂酰肌醇蛋白聚糖-3-预定位法检测肝细胞癌的MRI研究[D].广州:南方医科大学, 2015.
|
|
[27]ZHU D, QIN Y, WANG J, et al.Novel glypican-3-binding peptide for in vivo hepatocellular carcinoma fluorescent imaging[J].Bioconjug Chem, 2016, 27 (3) :831-839.
|
|
[28]QU Z, JIANG C, WU J, et al.Lenalidomide induces apoptosis and inhibits angiogenesis via caspase 3 and VEGF in hepatocellular carcinoma cells[J].Mol Med Rep, 2016, 14 (5) :4781-4786.
|
|
[29]LIU Y, CHEN Z, LIU C, et al.Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer[J].Biomaterials, 2011, 32 (22) :5167-5176.
|
|
[30]PANVICHIAN R, TANTIWETRUEANGDET A, SORNMAYURA P, et al.Missense mutations in exons 18-24 of EGFR in hepatocellular carcinoma tissues[J].Biomed Res Int, 2015, 2015:171845.
|
|
[31]SOGAWA C, TSUJI AB, YOSHIDA C, et al.Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma[J].Nucl Med Commun, 2012, 33 (7) :719-725.
|
|
[32]ZHAO P, YANG X, QI S, et al.Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes[J].Biomed Res Int, 2013, 2013:759057.
|
|
[33]YUAN S, FANG X, XU Y, et al.An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells[J].Oncotarget, 2016, 7 (37) :60491-60502.
|
|
[34]QIU K, WANG BC, CHEN ZN, et al.99m Tc-labeled HAb18Mc Ab Fab fragment for radioimmunoimaging in nude mice bearing human hepatocellular carcinoma[J].World J Gastroenterol, 1998, 4 (2) :117-120.
|
|
[35]LIU YL.The targeted-direeted probe (Hab18-SPIO) and its experimental study in the nude mice model gratfed with human HCC[D].Xi'an:The Fourth Military Med Univ, 2004. (in Chinese) 刘燕丽.Hab18-SPIO磁共振造影剂的制备及其在荷人肝癌裸鼠模型中的实验研究[D].西安:第四军医大学, 2004.
|
|
[36]ZHANG SW.An experimental study of MRI targeted diagnosis of hepatocellular carcinoma by Habl8 coupled SPIO[D].Changsha:Central South Univ, 2013. (in Chinese) 张声旺.Hab18偶联SPIO靶向肝癌MR诊断的实验研究[D].长沙:中南大学, 2013.
|
|
[37]WU SP, LU WS, XU DW, et al.Hepatic intraarterial 131Ⅰ-HAb18F (ab') 2 radioimmunotherapy on PLC with different types of blood supply through DSA[J].J Intervent Radiol, 2007, 16 (4) :243-245. (in Chinese) 吴少平, 卢武胜, 徐大伟, 等.肝癌DSA血供类型与经肝动脉灌注~ (131) Ⅰ-HAb18F (ab') _2治疗后瘤体大小变化的关系探讨[J].介入放射学杂志, 2007, 16 (4) :243-245.
|
|
[38]YANG R, AN LY, MIAO QF, et al.Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes[J].Oncotarget, 2016, 7 (24) :35894-35916.
|
|
[39]ZHAO RC, ZHOU J, CHEN KF, et al.The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection[J].Neoplasma, 2016, 63 (2) :288-298.
|
|
[40]LIU MC, LIU L, WANG XR, et al.Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo[J].Int J Nanomedicine, 2016, 11:1395-1412.
|
|
[41]WANG ZL, GUO L, LI YG, et al.Preparation of folate-mediated superparamagnetic iron oxide-dopamine-folate and its in vitro MR imaging[J].Chin J Med Imaging Technol, 2011, 27 (2) :251-255. (in Chinese) 王中领, 郭亮, 李勇刚, 等.叶酸靶向超顺磁性氧化铁-多巴胺-叶酸纳米复合物的制备及体外MR成像[J].中国医学影像技术, 2011, 27 (2) :251-255.
|
|
[42]HUO T, DU X, ZHANG S, et al.Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta 3 receptorexpressed tumor-MR molecular imaging of angiogenesis[J].Eur J Radiol, 2010, 73 (2) :420-427.
|
|
[43]GUO Z, GAO M, ZHANG D, et al.Simultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesions[J].Sci Rep, 2016, 6:28812.
|
|
[44]HE H, TU X, ZHANG J, et al.A novel antibody targeting CD24 and hepatocellular carcinoma in vivo by near-infrared fluorescence imaging[J].Immunobiology, 2015, 220 (12) :1328-1336.
|
|
[45]WANG L, SU W, LIU Z, et al.CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma[J].Biomaterials, 2012, 33 (20) :5107-5114.
|
|
[46]MA X, CHENG Z, JIN Y, et al.SM5-1-conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy[J].Biomaterials, 2014, 35 (9) :2878-2889.
|
|
[47]CAI B, HUANG Z, WU Z, et al.Fabrication of RGD-conjugated Gd (OH) (3) :Eu nanorods with enhancement of magnetic resonance, luminescence imaging and in vivo tumor targeting[J].Dalton Trans, 2016, 45 (36) :14063-14070.
|
|
[48]LIU J, ZHOU S, REN J, et al.A lysosome-locating and acidic p H-activatable fluorescent probe for visualizing endogenous H2O2in lysosomes[J].Analyst, 2017, 142 (23) :4522-4528.
|
|
[49]van der VORST JR, SCHAAFSMA BE, HUTTEMAN M, et al.Near-infrared fluorescence-guided resection of colorectal liver metastases[J].Cancer, 2013, 119 (18) :3411-3418.
|
|
[50]LIU Y, ZHAO YM, AKERS W, et al.First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent:a pilot study[J].Transl Res, 2013, 162 (5) :324-331.
|
DownLoad: